Phosphorylethanolamine.
A building block your cells use to make the ethanolamine phospholipids in every membrane. A supplement supplies it directly, on the idea of feeding membrane building and repair.
- Category
- Compound
What Phosphorylethanolamine is, and what it does.
- Does it work
- Of interest to people who follow membrane and phospholipid nutrition closely. This one is bought on mechanism rather than on human outcome trials, which are scarce.
- How much to take
- No daily amount is on record. Start from the figure on your label, and note that lecithin delivers the same building block inside a whole phospholipid instead.
- Time to feel it
- Nobody has measured a time course in people. Membrane turnover runs over days to weeks, so any change would be slow and would read out in a laboratory measure.
- The first dose
- Day one passes quietly. Membrane building runs at its own pace, and what shifts on the first day sits in cell chemistry rather than in a sensation.
- With regular use
- Weeks of daily use feed a pathway that rebuilds membranes continuously. Whether that moves anything a person can measure has not been tested in humans yet.
- How well tolerated
- It's a normal constituent of human plasma and urine and is usually well tolerated. Long-term human data is limited, so check with a doctor if you're pregnant or on medication.
- How it feels
- Neutral. No warmth, no lift, no taste worth reporting. The action is at the membrane level, which shows up in cell chemistry rather than in sensation.
- The overlooked benefit
- Your own sphingolipid recycling makes it around the clock, and it turns up on metabolomic panels, where low alkaline phosphatase activity raises the reading.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Committed intermediate of the CDP-ethanolamine branch of membrane phospholipid synthesisNarrative review
- Normal plasma and urinary metabolite measured in metabolomic panelsCohort study
- Membrane curvature and organelle shape from ethanolamine phospholipidsIn vitro study
- Oral absorption of the charged moleculeAnimal study
- Product of sphingosine-1-phosphate breakdownNarrative review
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Phosphoethanolamine and phosphocholine are the parallel intermediates of the two branches of the Kennedy pathway, feeding phosphatidylethanolamine and phosphatidylcholine respectively. They draw on the same CTP pool and the same diacylglycerol pool at the final condensation step. Supplying both branches at once is what a mixed phospholipid preparation does by default. This is membrane building block arithmetic, not evidence that either intake changes a health outcome.
The liver converts phosphatidylethanolamine to phosphatidylcholine through three sequential methylations by PEMT, and each one consumes an S-adenosylmethionine molecule. Without adequate methyl donor supply that route stalls and the cell leans harder on the choline branch. So the fate of anything entering the ethanolamine branch depends on methylation status.
Betaine donates a methyl group to homocysteine to regenerate methionine, which is what refills the SAM-e pool that PEMT draws on. The three methylations that turn phosphatidylethanolamine into phosphatidylcholine are among the largest consumers of SAM-e in the liver. Betaine intake and the ethanolamine branch of phospholipid synthesis are therefore linked through the same methyl budget.
5-methyltetrahydrofolate supplies the other route back to methionine, working through methionine synthase alongside the betaine route. Both routes ultimately determine how much SAM-e is available for phospholipid methylation. This is a supply relationship in shared metabolism and says nothing about a clinical effect of taking phosphoethanolamine itself.
Methionine synthase needs methylcobalamin to move the folate methyl group onto homocysteine. When B12 is low that transfer fails and folate becomes trapped in its methyl form, which constrains the same SAM-e pool the phospholipid methylation route depends on. The dependency is a chain, so the weakest link in it sets the ceiling.
Sphingosine-1-phosphate lyase is a pyridoxal-5-phosphate dependent enzyme, and the reaction it catalyses releases phosphoethanolamine along with a fatty aldehyde. That is one of the endogenous routes by which phosphoethanolamine is generated, tying sphingolipid turnover to the ethanolamine pool. Low B6 status slows that step.
Ethanolamine kinase phosphorylates ethanolamine using ATP, and like essentially all kinases it acts on the magnesium-ATP complex rather than on free ATP. Magnesium is therefore an obligate participant in the first committed step of the ethanolamine branch. This applies to every ATP-dependent step in the pathway, not just this one.
Mammalian cells make phosphatidylserine by swapping the head group of phosphatidylethanolamine for serine, and they can run the exchange in the other direction by decarboxylating phosphatidylserine back to phosphatidylethanolamine in the mitochondria. The two lipids are interconvertible rather than independent. Anything shifting the ethanolamine pool therefore touches the serine pool as well.
Serine is the head group donor in the base exchange reaction that converts phosphatidylethanolamine to phosphatidylserine. Serine availability is one determinant of how the two head group pools distribute. This is bench biochemistry and has not been shown to be rate limiting at ordinary dietary serine intakes.
Phosphatidylcholine and phosphatidylethanolamine are the two dominant phospholipids in mammalian membranes, and their ratio governs membrane curvature and the behaviour of proteins embedded in the bilayer. Supplying one head group family without the other shifts that ratio in cell models. Mixed phospholipid preparations supply both, which is why they are formulated that way.
Commercial lecithin is a phospholipid mixture in which phosphatidylethanolamine typically sits second by weight behind phosphatidylcholine. Anyone taking lecithin is already taking the ethanolamine-headed phospholipid, delivered as an intact lipid rather than as the free phosphomonoester. The two are not interchangeable in the gut, since the intact lipid is digested by phospholipases before absorption.
Ethanolamine-headed phospholipids in neural and retinal tissue are unusually enriched in docosahexaenoic acid at the second position of the glycerol backbone. The head group and the fatty acid are assembled into the same molecule, so the supply of both matters to the final species produced. Measurements of membrane composition are not the same as a functional outcome, and that distinction holds here.
Phosphatidylethanolamine generated inside mitochondria by phosphatidylserine decarboxylase is a structural requirement for normal cristae shape and for the assembly of respiratory chain supercomplexes, which is the environment coenzyme Q10 works in. Whether supplemental intake of either shifts that environment in a person has not been shown. Read the pairing as mechanistic context rather than as a recommendation to combine them.
Nothing specific on file for Phosphorylethanolamine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Phosphorylethanolamine actually does.
It is step one on the assembly line that builds one of the two main fats in every cell membrane.
The bottleneck sits one step past this compound, which is why simply supplying more of it does not automatically make more membrane lipid.
The body makes this compound on its own every time it breaks down a particular signalling lipid.
It already circulates in everyone, and lab panels measure it.
Where Phosphorylethanolamine comes from.
It is a small phosphate-carrying molecule your cells already make constantly while building and recycling membranes. Sold on its own it is a lab-made salt. Sold inside lecithin it is part of a whole fat molecule that gets taken apart during digestion.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Industrially, ethanolamine comes from ethylene oxide and ammonia. Biologically the pool comes from membrane phospholipid turnover, from sphingosine-1-phosphate breakdown and from gut bacterial metabolism
Chemical phosphorylation with phosphoryl chloride or polyphosphoric acid in the synthetic route, or enzymatic transfer from ATP by ethanolamine kinase in the body
Product separated from unreacted amine and inorganic phosphate, then converted to the calcium or sodium salt
Identity and purity confirmed, with residual free ethanolamine and inorganic phosphate as the limits that matter
Blended with carriers, or supplied as part of a phospholipid concentrate where it is one component among several
Getting Phosphorylethanolamine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Targeted plasma metabolomics found altered glycolytic flux and a stalled TCA cycle pattern, with phosphoethanolamine among the metabolites profiled.Case-control. Tang Y et al., 2025 (Scientific Reports). PMID 41034373 ↗
- Phosphorus availability shaped the soil microbial community through plant root signalling, with phosphorus-containing metabolites including phosphoethanolamine among those tracked.In vitro study. Cao Y et al., 2024 (Microbiome). PMID 39342390 ↗
These are the studies our verdict leans on, chosen from the 2 we read for Phosphorylethanolamine. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.